Octapharma USA Focuses on Urgent Surgeries as FDA Approves octaplex® for Fast Track Development
Therapy May Stem Spontaneous Bleeding Episodes, Mortality Rates The U.S. Food and Drug Administration (FDA) has approved Octapharma USA’s Investigational New Drug Application for octaplex® (Human Prothrombin Complex,...
Octapharma Clinical Trial Begins in the US and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
Multi-Center Study Investigates Prospects of Improved Safety, Immunogenicity
Octapharma is Terminating the Plasma Therapeutics Association Global Membership
Octapharma has notified the Plasma Protein Therapeutics Association that it is terminating its Global Membership and Regional Membership in the organization.